Bioceltix S.a. Bioceltix S.a.

Bioceltix S.a.

BCX

Rank in Stocks #19653
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals... Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The companyโ€™s products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Share Price
$17.22
Last synced: 2026-11-16
Market Cap
$95.26M
Change (1 day)
-2.06%
Change (1 year)
-30.27%
Country

Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this

Category

Healthcare
EPS for Bioceltix S.a. (BCX)
EPS as of June 2026 TTM: $-0.87
According to Bioceltix S.a.'s latest financial reports, its current EPS (TTM) is $-0.87. At the end of 2025 the company had an EPS of $-0.84, a decrease compared to its 2024 EPS of $-0.80.
EPS history for Bioceltix S.a. from 2018 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.87 3.67%
2025 $-0.84 5.56%
2024 $-0.80 -10.12%
2023 $-0.89 45.72%
2022 $-0.61 76.89%
2021 $-0.34 35.15%
2020 $-0.25 97.90%
2019 $-0.13 100.62%
2018 $-0.06 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$15.66 -1,898.35%
US
$-7.07 711.90%
US
$-5.29 507.49%
AU
$12.73 -1,562.13%
BE
$21.56 -2,575.88%
NL

Questions about Bioceltix S.a.'s earnings per share (EPS)

What is Bioceltix S.a.'s earnings per share (EPS)?

Bioceltix S.a.'s earnings per share (EPS) over the last twelve months is $-0.87, as of Jun 2026.

What was Bioceltix S.a.'s earnings per share (EPS) in 2025?

In 2025, Bioceltix S.a.'s earnings per share (EPS) was $-0.84, compared with $-0.80 in 2024.

How has Bioceltix S.a.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, Bioceltix S.a.'s earnings per share (EPS) was highest in 2020 ($-0.25) and lowest in 2023 ($-0.89).

How does Bioceltix S.a.'s earnings per share (EPS) compare with similar companies?

Bioceltix S.a.'s earnings per share (EPS) ($-0.87) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.